Yaping Zhang on Platelet Adhesion Receptors
Yaping Zhang, Postdoc Associate at University of Illinois Chicago, shared on LinkedIn:
”Glad to participate in publishing the chapter “Platelet Adhesion Receptors” in the book Platelet Physiology I.
Andrew Mack, Yaping Zhang & Xiaoping Du
Platelet adhesion receptors are essential for platelet attachment, aggregation, and activation, which are critical for normal hemostasis and pathological thrombosis.
These receptors regulate where and how platelets adhere, influencing thrombus size and stability, and they trigger signaling pathways that coordinate with other adhesion and activation receptors to promote platelet spreading, secretion, clot retraction, and thrombus formation.
Platelets use several major receptor families—including integrins, LRR receptors such as GPIb-IX-V, immunoglobulin superfamily receptors like GPVI, and C-type lectins—to bind ligands such as collagen, von Willebrand factor, fibrinogen, and laminin, enabling interactions with vessel walls, other platelets, leukocytes, microbes, and tumor cells.
Because adhesion is central not only to hemostasis and thrombosis but also to inflammation and immune responses, targeting these receptors and their signaling pathways remains a key strategy for developing antithrombotic therapies.”
Read the chapter here.
Article: Platelet Adhesion Receptors
Authors: Andrew Mack, Yaping Zhang, Xiaoping Du
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery